Research and Development Expense (Annual) Chart

Historical Research and Development Expense (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
September 30, 2025 30.39M
September 30, 2024 31.52M
September 30, 2023 33.96M
September 30, 2022 27.54M
September 30, 2021 22.41M
September 30, 2020 16.12M
September 30, 2019 56.37M
September 30, 2018 46.94M
September 30, 2017 39.88M
September 30, 2016 51.54M
September 30, 2015 52.23M
September 30, 2014 52.65M
September 30, 2013 46.21M
September 30, 2012 47.46M
September 30, 2011 39.85M
September 30, 2010 31.16M
Date Value
September 30, 2009 31.61M
September 30, 2008 42.92M
September 30, 2007 51.72M
September 30, 2006 45.64M
September 30, 2005 63.12M
September 30, 2004 65.82M
September 30, 2003 72.89M
September 30, 2002 73.26M
September 30, 2001 60.87M
September 30, 2000 42.95M
September 30, 1999 22.42M
September 30, 1998 22.67M
September 30, 1997 14.22M
September 30, 1996 12.36M
September 30, 1995 6.396M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Agilent Technologies, Inc. 450.00M
Bio-Rad Laboratories, Inc. 257.60M
Bruker Corp. 395.20M
Danaher Corp. 1.598B
Harvard Bioscience, Inc. 8.825M